RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 34-44
  • FDA panel recommends continued Avandia sales, with restrictions

    FDA panel recommends continued Avandia sales, with restrictions
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
  • Things to know for Monday

    Things to know for Monday
    More than a dozen firefighters in Arizona died this weekend, political demonstrations in Brazil were suppressed by more than 10,000 troops, and Egypt is seeing resurgent political demonstrations of its own. Welcome to your post-weekend trends report for...
  • Animal studies riddled with bias, report finds

    Animal studies riddled with bias, report finds
    Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials. Researchers examined data from thousands of experiments...
  • U.S. HPV vaccination rates far from goal, officials say

    U.S. HPV vaccination rates far from goal, officials say
    WASHINGTON (Reuters) - Only slightly more than half of U.S. girls aged 13 to 17 had been vaccinated against a virus that can cause cervical and other cancers last year, and a top U.S. health official said on Thursday that more must be done to bring the...
  • Deals of the day -- mergers and acquisitions

    July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...
  • LGBT ally groups can improve an office

    LGBT ally groups can improve an office
    As human beings, we are at our best when we can be ourselves, when we live without fear of judgment or the pressures of putting on airs. As workers, logically, it's no different. An employee living authentically, unencumbered by the distractions of...
  • 9th Circuit bans juror exclusion over sexual orientation

    SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
  • Looking Out: Jurors can't be excluded based on sexual orientation, court says

    Looking Out: Jurors can't be excluded based on sexual orientation, court says
    In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations. Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
  • FDA affirms safety of diabetes drug Avandia, lifts restrictions on use

    FDA affirms safety of diabetes drug Avandia, lifts restrictions on use
    Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration. Federal regulators said Monday that the...
  • Televised confessions in China raise worries

    Televised confessions in China raise worries
    BEIJING — The headline news on state-run Chinese Channel 13 was juicy: A mining tycoon and 35 others had been charged with running a mafia-style enterprise in Sichuan province, gunning down enemies in the street, bribing people and operating an...
  • CVS' halt on tobacco wins praise

    CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...